2:2s Quality Control Violation With Pending Patient Results
Community Diagnostics runs a two-level chemistry quality control program on its analyzer. On Tuesday morning, the level 2 glucose control is 2.9 SD above the mean; the previous run's level 2 control was 2.2 SD above the mean. The level 1 control is within 1 SD. The analyzer was calibrated two weeks ago, and the reagent lot was changed five days ago. There are 40 patient glucose results pending, including a fasting glucose of 48 mg/dL and a glucose of 512 mg/dL. The evening technologist wants to release all results because no control exceeds 3 SD and the analyzer's calibration was "recent." The laboratory's written QC procedure states that 2:2s is a rejection rule but does not specify what to do with patient results already reported since the last acceptable QC. The laboratory director is out of town, and the shift supervisor asks you to decide whether to report the pending results.
1. Apply the laboratory's QC rules. Is the Tuesday run acceptable? What actions must occur before patient results are reported?
Read the worked answer
The run is not acceptable. The current level 2 control is 2.9 SD above the mean, and the previous level 2 control was 2.2 SD above the mean. That is a 2:2s pattern on the same side of the mean, and the laboratory's procedure defines 2:2s as a rejection rule. The fact that no single control exceeds 3 SD does not make the run acceptable.
Before reporting patient results, the laboratory must:
- Stop reporting glucose results.
- Repeat the controls to confirm the violation.
- Check likely causes: reagent lot change, calibration, deterioration, pipetting, temperature, or analyzer maintenance.
- Recalibrate or correct the identified problem.
- Repeat QC until it is acceptable.
- Re-run affected patient samples or verify them by an alternative method before release.
The supervisor should not release the 40 pending results on the rationale that calibration was "recent." A 2:2s rejection indicates a systematic shift that may bias patient results.
2. What should be done about patient results reported since the last acceptable QC, including the critical results?
Read the worked answer
The laboratory must review patient results reported since the last acceptable QC, not only the pending batch. The critical values of 48 mg/dL and 512 mg/dL require particular attention because an analytical shift could change clinical decisions.
Actions:
- Identify all glucose results reported since the last acceptable QC.
- Repeat the critical samples immediately on a functioning method, if available.
- Review results for delta checks, implausible values, and clinical consistency.
- If erroneous results were reported, notify the ordering clinician promptly and document the corrected report.
- Do not release the pending critical results until QC is acceptable or the results are verified by an alternative method.
- If delay would harm a patient, communicate the limitation to the clinician rather than silently reporting an unverified result.
The judgment is that patient safety requires both a technical fix and a review of already-reported results.
3. The QC procedure is incomplete. What elements should a compliant QC procedure include, and what is the regulatory risk of releasing results now?
Read the worked answer
A compliant QC procedure should specify:
- Which control materials are used and how they are prepared and stored.
- Frequency of QC, including with reagent lot changes and after calibration.
- Acceptance limits and rejection rules, such as 1:3s, 2:2s, and other defined rules.
- Actions to take when QC fails, including repeating, troubleshooting, recalibration, and maintenance.
- How patient results are handled, including holding, retesting, and reviewing results since the last acceptable QC.
- Documentation, review, and director oversight.
Releasing results now creates regulatory and clinical risk. The laboratory would be reporting patient results when its own QC procedure says the run should be rejected. That is a QC deficiency and could support a condition-level finding. Clinically, a systematic shift could produce falsely low or high glucose values. The supervisor should hold the results, correct the QC failure, and document the review rather than release results because the director is unavailable.